Known for his integral role as the ex-president US operations for Swiss company, Amneal Pharmaceuticals GmbH, Dr. Vaczi offers valuable insight in medical, sales, business development, finance and administration. He holds a Summa cum Laude degree from the Szent-Györgyi Albert Medical University, Hungary.
As the Managing Director at Extrovis’s flagship in Switzerland, Dr. Vaczi brings with him an in-depth knowledge and well rounded set of skills in medical, sales, business development, finance and administration, integral for Extrovi’s commercial and partnership strategy. He is solely responsible for shaping the company’s portfolio and execution of all development projects.
The Chief Strategic Officer at Extrovis, Hanumantha has a master’s degree in International Management from Pondicherry Central University, India. He combines a strong knowledge of industry trends and portfolio strategy with a vast professional network. Prior to his role at Extrovis Switzerland, Hanumantha held various managerial positions in the areas of strategic sourcing, portfolio management and strategic business development at Amneal, Ranbaxy and Dr. Reddy’s.
A graduate in veterinary sciences from one of India’s top leading institutions, Dr. Mallikarjun has spent over two decades in animal healthcare and service. His passion for healthcare and stellar record as a leader in previous projects brings great value. Dr. Mallikarjun has assumed the position of Head of India operations at Extrovis AG.
Dr. Rajasekhara brings to Extrovis over 15 years of research and development experience in complex genetics, including but not limited to liposomal, microsphere and nanoparticle technology, and drug device combinations. With a PhD in Pharmaceutical Sciences and the co author of several scientific publications, Dr. Rajasekhara has held various R&D management positions at renowned companies such as Alembic, Hospira, Leiutis, Dr. Reddy’s and Gland. Here at Extrovis, he is focused on leading the company’s efforts to ideate and implement a robust complex generics portfolio.
As Chief Scientific Officer at Extrovis, Dr. Hanumantharao brings over 20 years of experience and expertise in process research and development, API manufacturing and technology transfer, and is responsible for the robust execution of API development programmes for Extrovis. He has held various management positions at reputed pharmaceutical companies such as Aurobindo, Azico Biophors and Caplin Point. His impressive academic background, which includes a PhD degree in organic chemistry and a co-authors title for several scientific publications, underpins his scientific knowledge with his acute business acumen and expertise in managing research and development organisations.